Research grade mRNA, saRNA, circRNA and polycistronic RNA by in vitro transcription (IVT), from sequence design and optimization through purification and quality control. 

Tebubio provides custom RNA production and RNA synthesis services for research and preclinical applications.

Research grade (RUO) RNA is available from 100 µg to 10 mg, with RNA constructs up to 10 kb. RNA can be customized according to your experimental requirements, including 5′ capping, modified nucleotide incorporation, poly(A) tailing, and fluorescent labeling.  

Our workflows support the production of:

mRNA

Messenger RNA
CAP Gene poly(A)
Protein

For short-term expression of various types of proteins.

saRNA

Self-amplifying RNA
CAP Replicase Gene poly(A)
Protein production

For high and long-lasting expression.

circRNA

Circular RNA
IRES Gene
Protein

For durable cap-independent expression.

Polycistronic RNA

Multiple coding sequences
CAP Gene 1 2A Gene 2 2A Gene 3 poly(A)
Multiple proteins

For co-expression of multiple targets, including multi-antigen and multi-subunit applications.

From Design to Functional Validation: An RNA Workflow Tailored to Your Needs 

We can support your project from RNA sequence design, codon optimization and DNA template preparation to IVT, purification and quality control, as well as with downstream delivery or expression studies. 

Our workflows can be readily adapted to incorporate virtually any modification or reagent, including client-provided. 

DNA Template &
Sequence Optimization
  • Plasmid and linear DNA
  • Templates for mRNA, saRNA, circRNA and polycistronic RNA
  • Enhanced protein expression
  • Reduced immunogenicity
  • Minimized truncated products
OR
Your DNA Template
RNA Production
  • 100 µg to 10 mg, up to 10 kb
  • Choice of capping, modified and fluorescent nucleotides
  • Various purification methods and quality controls
OR
Your capping, nucleotides or enzymes
Delivery
  • Chemical transfection or LNP
  • Encapsulation from 10 µg to 5 mg RNA
  • Large choice of lipids, including conjugated
OR
Your RNA, LNP, lipids or reagents
In Vitro RNA Testing
  • Cell lines and primary cells 2D and 3D
  • Uptake, delivery, expression
  • Cellular response
  • Functional activity
  • Inflammation
  • Plasmid and linear DNA
  • Templates for mRNA, saRNA, circRNA and polycistronic RNA
  • Enhanced protein expression
  • Reduced immunogenicity
  • Minimized truncated products
  • 100 µg to 10 mg, up to 10 kb
  • Choice of capping, modified and fluorescent nucleotides
  • Various purification methods and quality controls
  • Chemical transfection or LNP
  • Encapsulation from 10 µg to 5 mg RNA
  • Large choice of lipids, including conjugated
  • Cell lines and primary cells 2D and 3D
  • Uptake, delivery, expression
  • Cellular response
  • Functional activity
  • Inflammation
OR
Your DNA Template
OR
Your capping, nucleotides or enzymes
OR
Your RNA, LNP, lipids or reagents

DNA template

Choose our optimized templates for mRNA, saRNA, circRNA and polycistronic RNA, or provide your own. 

Sequence optimization

Ensure enhanced protein expression and reduced immunogenicity while minimizing truncated RNA products. 

RNA Production 

Customize your RNA according to your research needs, including 5′ capping, modified nucleotide incorporation, poly(A) tailing, and fluorescent labeling.  

Customize Your RNA for Your Research Application

Research Grade (RUO) RNA quality

RNA production from 100 µg to 10 mg, supporting early research and preclinical workflows.

5′ Capping

Select the appropriate capping strategy for your RNA construct and downstream application.

Modified Nucleotides

Incorporate modified nucleotides such as pseudouridine according to your experimental requirements to make your RNA more stable and improve its translation.

Poly(A) Tail

Customize poly(A) tail characteristics to support RNA stability and translation studies.

Fluorescent RNA Labeling

Use fluorescently labeled RNA, including options such as Cy5, for RNA tracking, uptake and localization studies.

Formulation in LNP

Select from a large library of lipids, including conjugated to fluorescent dyes and peptides, and get your RNA ready for delivery studies by encapsulation in lipid nanoparticles (LNP). 

Cell validation

Characterize RNA delivery, uptake, expression and biological activity in relevant 2D/3D models, combining advanced imaging, functional assays and biomarker analysis to support functional proof-of-concept. 

End-to-end solutions: from RNA to biological validation 

Tebubio supports every stage of your RNA project with integrated solutions designed to streamline the transition from RNA production to in vivo applications. 

Why Choose Tebubio for Custom RNA Production?

500+ RNA projects completed
Experience supporting complex RNA research projects from early development through preclinical studies.
FLEXIBILITY Flexible RNA formats
mRNA, saRNA, circRNA and polycistronic RNA with customizable sequences and production parameters.
PERFORMANCE Proven RNA Performance Across Applications
From therapeutic and delivery solution development to structural studies (NMR and cryoEM) and PCR-based quality control.
INTEGRATION One partner across the workflow
Connect RNA production with LNP formulation and biological validation without having to coordinate multiple CROs.
RECOGNITION & SUPPORT
Our RNA platform has been awarded by the France 2030 investment plan for French technological competitiveness and supported by Bpifrance.

Why Choose Tebubio as Your Laboratory Service Provider

EXPERTISE

PhD-level expertise

Scientific guidance tailored to your research question.

FLEXIBILITY

Support at the right scale

From a single assay to a complete study, with solutions that evolve with your project.

SIMPLICITY

One partner, less complexity

From study design to results, with a dedicated project manager by your side.

ACCESSIBILITY

European expertise, global reach

Your research, handled in France, with close collaboration and support for researchers in Europe.

Scientific Resources 

Explore how to optimize Lipid Nanoparticules for mRNA delivery for drug development.  

This study highlights key formulation parameters: buffer composition, lipid selection; crucial for enhancing transfection and therapeutic efficacy.  

Xavier Warnet PhD, our CRO's project manager published a review on how scientists have developed lipid nanoparticles (LNPs) that make it possible to deliver RNA in a more precise manner, paving the way for future development in oncology.

Choose Tebubio as Your Laboratory Service Provider

EXPERTISE

PhD-level expertise

Scientific guidance tailored to your research question.

FLEXIBILITY

Support at the right scale

From a single assay to a complete study, with solutions that evolve with your project.

SIMPLICITY

One partner, less complexity

From study design to results, with a dedicated project manager by your side.

ACCESSIBILITY

European expertise, global reach

Your research, handled in France, with close collaboration and support for researchers in Europe.

Book Your Feasability Call